SELLAS Life Sciences Group, Inc (SLS) Tops Q1 EPS by 2c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SELLAS Life Sciences Group, Inc. announced topline data from the Phase 2a study of SLS009 and provides an update on Phase 3 REGAL Study of GPS in AML. The REGAL Steering Committee met on March 22,.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 3,120,000 shares, a decrease of 19.6% from the January 15th total of 3,880,000 shares. Based on an average daily trading volume, of 990,800 shares, […]
SELLAS Life Sciences (SLS) Announces Publication of Preclinical Data on its Highly Selective CDK9 Inhibitor, SLS009, in Oncotarget streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.